Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1932 1
1945 1
1947 1
1949 2
1950 1
1952 1
1953 1
1963 1
1965 1
1966 2
1967 13
1968 16
1969 8
1970 4
1971 2
1973 1
1974 2
1975 5
1976 11
1977 5
1978 2
1979 8
1980 7
1981 7
1982 6
1983 3
1984 8
1985 13
1986 10
1987 12
1988 19
1989 11
1990 10
1991 10
1992 13
1993 12
1994 10
1995 7
1996 16
1997 22
1998 12
1999 14
2000 19
2001 22
2002 22
2003 22
2004 19
2005 23
2006 27
2007 29
2008 28
2009 35
2010 47
2011 35
2012 35
2013 51
2014 48
2015 43
2016 43
2017 38
2018 25
2019 28
2020 33
2021 26
2022 20
2023 10

Text availability

Article attribute

Article type

Publication date

Search Results

958 results

Results by year

Filters applied: . Clear all
Page 1
Infantile Acne.
Poole CN, McNair V. Poole CN, et al. 2022 Jul 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. 2022 Jul 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 31082168 Free Books & Documents.
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).
Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C, Hale D, Dunn JA, Lyman GH, Hutchinson C, MacCallum P, Kakkar A, Hobbs FDR, Petrou S, Dale J, Poole CJ, Maraveyas A, Levine M. Young AM, et al. Among authors: poole cj. J Clin Oncol. 2018 Jul 10;36(20):2017-2023. doi: 10.1200/JCO.2018.78.8034. Epub 2018 May 10. J Clin Oncol. 2018. PMID: 29746227 Clinical Trial.
First-Line Trastuzumab Plus an Aromatase Inhibitor, With or Without Pertuzumab, in Human Epidermal Growth Factor Receptor 2-Positive and Hormone Receptor-Positive Metastatic or Locally Advanced Breast Cancer (PERTAIN): A Randomized, Open-Label Phase II Trial.
Rimawi M, Ferrero JM, de la Haba-Rodriguez J, Poole C, De Placido S, Osborne CK, Hegg R, Easton V, Wohlfarth C, Arpino G; PERTAIN Study Group. Rimawi M, et al. Among authors: poole c. J Clin Oncol. 2018 Oct 1;36(28):2826-2835. doi: 10.1200/JCO.2017.76.7863. Epub 2018 Aug 14. J Clin Oncol. 2018. PMID: 30106636 Clinical Trial.
The state of the art in planar chromatography.
Poole C, Wilson ID. Poole C, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Jul 1;1203:123309. doi: 10.1016/j.jchromb.2022.123309. Epub 2022 May 21. J Chromatogr B Analyt Technol Biomed Life Sci. 2022. PMID: 35635938 No abstract available.
958 results